Gerresheimer AG
- Weblinks
- Social Web
- Sprache:
- Medien:
- Zeitraum:
- Zeitraum:Gesamt
- 2mehr
Gerresheimer awarded EcoVadis Gold status again
Duesseldorf (ots) - - Gerresheimer among the top 5% of assessed businesses - Total score increases to 72/100 points - Status demonstrates consistent implementation of CSR strategy Gerresheimer, an innovative provider of systems and solutions and a global partner for the pharma, biotech, and cosmetic industries, has once again been awarded Gold status by the ratings agency EcoVadis. EcoVadis assesses the performance of ...
mehrGerresheimer at CPHI: focus on high-value solutions and sustainability
Duesseldorf (ots) - - Gerresheimer presents an extensive portfolio of containment solutions, drug delivery systems and digital therapy support - High-quality ready-to-fill solutions for biopharmaceuticals, cell and gene therapy - EcoDesign and environmentally friendly packaging options ensure greater sustainability Gerresheimer, an innovative system and solution ...
mehrGerresheimer with a good start to 2023 financial year: Again double-digit growth in revenues and Adjusted EBITDA
Düsseldorf (ots) - - First-quarter revenues grew organically by 21.0% - Adjusted EBITDA up organically by 24.8% - Gerresheimer confirms guidance for financial year 2023 Gerresheimer AG, a leading provider of healthcare & beauty solutions and drug ...
Ein DokumentmehrGerresheimer 2022: Profitable growth company boosting revenue and adjusted EBITDA growth to double-digit levels
Duesseldorf (ots) - - Consistent execution of strategy and strong fourth quarter performance has resulted in organic revenue growth of 16.2% for FY 2022 - Organic growth in adjusted EBITDA of 10.2% for FY 2022, ahead of guidance - Q4 2022 delivered ...
Ein DokumentmehrGerresheimer and Corning announce joint venture to meet growing demand for Velocity® Vials, accelerating the delivery of lifesaving treatments
Düsseldorf (ots) - Gerresheimer AG, the leading global provider of healthcare, beauty, and drug delivery systems for pharma, biotech, and cosmetics, today announced a joint venture with Corning Incorporated (NYSE: GLW), a leading innovator in materials science and manufacturing, to increase global access to the ...
mehrGerresheimer to expand significantly in High Value Solutions and further accelerates its sustainable profitable growth
Düsseldorf (ots) - At today’s Capital Markets Day, Gerresheimer AG, a leading provider of healthcare & beauty solutions and drug delivery systems for pharma, biotech and cosmetics, reaffirmed its growth agenda and increased its revenue and adjusted ...
Ein DokumentmehrGerresheimer AG and Stevanato Group present EZ-fill Smart™, a new and innovative Ready-To-Fill Vial Platform
Düsseldorf, Germany / Piombino Dese, Italy (ots) - Gerresheimer AG, a leading global provider of healthcare & beauty and drug delivery systems for pharma, biotech and cosmetics and Stevanato Group S.p.A. (NYSE: STVN), a global provider of drug containment, drug delivery and diagnostic solutions to the ...
mehrGerresheimer and Merck Transform Primary Packaging into Digital Twins
Düsseldorf (ots) - Gerresheimer AG, a leading provider of healthcare solutions and drug delivery systems for pharma, biotech and cosmeticsand Merck, Darmstadt, a leading science and technology company, jointly developed a digital twin solution to further ensure traceability and trust in crucial steps along the pharmaceutical supply chain. The proof of concept aims to ...
mehr
Gerresheimer reports double digit growth in revenue and earnings for the third quarter
Duesseldorf (ots) - - Organic revenue growth of 17.4% in the third quarter supported by continued strong demand for High Value Solutions - Organic adjusted EBITDA up 13.3% - Gerresheimer firmly on track to deliver on FY 2022 guidance Gerresheimer AG, a leading provider of healthcare & beauty solutions ...
Ein DokumentmehrGerresheimer AG and Stevanato Group announce Collaboration on the Development of an innovative Ready-To-Use Vial Platform for the Pharmaceutical Industry
Düsseldorf, Germany / Piombino Dese, Italy (ots) - - Two leading companies joined forces to develop a new Ready-To-Use solution platform based on EZ-fill® pre-sterilized platform - Seamless integration into standard fill & finish lines - Significant increase in quality and efficiency Gerresheimer AG, a leading ...
mehrGerresheimer and Zollner enter into a strategic partnership for electronically controlled medtech systems from a single source
Düsseldorf/Zandt (ots) - Gerresheimer AG and Zollner Elektronik AG are pooling their market-leading pharmaceutical and medical technology expertise under a strategic partnership. Starting immediately, they will offer pharmaceutical, healthcare and biotech companies their conceptual design, development and ...
mehrGerresheimer invests up to 94 million Dollar in US production facility
Morganton, NC (ots) - - Major expansion in the North American market - Supported by U.S. Biomedical Advanced Research and Development Authority (BARDA) via 70/30 cost-share cooperative agreement - New state-of-the-art forming lines in North Carolina increase annual production capacity for Glass Vials in the U.S. significantly Gerresheimer AG, a leading provider of ...
mehrGerresheimer on track to deliver record financial year 2022 after solid second quarter
Ein DokumentmehrGerresheimer signs new credit facility in the amount of 150 million Euro
mehrGerresheimer partners with MedTech start-up Adamant Health to revolutionize treatment of Parkinson’s disease
Duesseldorf/Kuopio (ots) - - Partners join forces to improve lives of millions of Parkinson’s patients worldwide with a transformative technology-based solution - Gerresheimer participates in seed-round of the Finnish MedTech company and university spin-off - Monitoring and personalized medication adjustment in ...
mehrAnnual General Meeting of Gerresheimer AG approves dividend of EUR 1.25 per share following a successful financial year – Gradual renewal of Supervisory Board initiated
Duesseldorf (ots) - The Annual General Meeting of Gerresheimer AG has approved the payment of a dividend of EUR 1.25 per share for the 2021 financial year. This represents a payout ratio of 30 percent. “2021 was a record year for us. Our formula G strategy process and the investments in transforming our ...
mehrGerresheimer executes on its growth strategy in Emerging Markets boosting capacities in India
Duesseldorf/Kosamba (ots) - Gerresheimer has significantly ramped up its glass and plastic production capacities in India to satisfy its global pharma customer needs. A new modern plant to produce high quality plastic containers and closures was built at the Kosamba site, and glass production received a new ...
mehr